BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31201432)

  • 1. Performance of a machine learning-based decision model to help clinicians decide the extent of lymphadenectomy (D1 vs. D2) in gastric cancer before surgical resection.
    Liu C; Qi L; Feng QX; Sun SW; Zhang YD; Liu XS
    Abdom Radiol (NY); 2019 Sep; 44(9):3019-3029. PubMed ID: 31201432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Intelligent Clinical Decision Support System for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.
    Feng QX; Liu C; Qi L; Sun SW; Song Y; Yang G; Zhang YD; Liu XS
    J Am Coll Radiol; 2019 Jul; 16(7):952-960. PubMed ID: 30733162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
    Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
    World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
    Sun D; Gong R; Wu H
    Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 versus D2 Gastrectomy for Gastric Adenocarcinoma.
    Lavy R; Hershkovitz Y; Chikman B; Shapira Z; Poluksht N; Yarom N; Sandbank J; Halevy A
    Isr Med Assoc J; 2015 Dec; 17(12):735-8. PubMed ID: 26897973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
    Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials.
    Mocellin S; Nitti D
    Cancer Treat Rev; 2015 May; 41(5):448-54. PubMed ID: 25814393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
    Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
    Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term outcomes of laparoscopic D2 lymphadenectomy with complete mesogastrium excision for advanced gastric cancer.
    Xie D; Yu C; Liu L; Osaiweran H; Gao C; Hu J; Gong J
    Surg Endosc; 2016 Nov; 30(11):5138-5139. PubMed ID: 27005289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
    Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
    Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.